NICA.ST
Price:
$1.14
Market Cap:
$100.73M
Nanologica AB (publ), a nanotechnology company, develops nanoporous silica for applications in the life science industry. The company offers nanoporous silica particles for drug development and chromatography separation. It provides NLAB Silica, a technology platform for drug delivery; NLAB Spiro, an inhalation platform for pulmonary drug delivery; SVEA (U)HPLC analytical columns; and preparative chromatography. Nanologica AB (publ) was founded in 2004 and is based in Södertälje, Sweden.
Industry
Biotechnology
IPO Date
2015-10-30
Stock Exchange
STO
Ticker
NICA.ST
According to Nanologica AB (publ)’s latest financial reports and current stock price. The company's current ROE is -164.35%. This represents a change of -520.45% compared to the average of 39.09% of the last 4 quarters.
The mean historical ROE of Nanologica AB (publ) over the last ten years is 186.51%. The current -164.35% ROE has changed -188.12% with respect to the historical average. Over the past ten years (40 quarters), NICA.ST's ROE was at its highest in in the December 2023 quarter at 1.94%. The ROE was at its lowest in in the March 2024 quarter at -154.34%.
Average
186.51%
Median
-88.33%
Minimum
-1036.69%
Maximum
3.96%
Discovering the peaks and valleys of Nanologica AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 917.02%
Maximum Annual ROE = 3.96%
Minimum Annual Increase = -5358.50%
Minimum Annual ROE = -1036.69%
Year | ROE | Change |
---|---|---|
2024 | -88.55% | -102.24% |
2023 | 3.96% | -5358.50% |
2022 | -75.30% | -22.50% |
2021 | -97.16% | 263.84% |
2020 | -26.70% | -94.88% |
2019 | -521.07% | 491.41% |
2018 | -88.11% | -91.50% |
2017 | -1036.69% | 917.02% |
2016 | -101.93% | 72.18% |
2015 | -59.20% | -67.19% |
The current ROE of Nanologica AB (publ) (NICA.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.27%
5-year avg
734.42%
10-year avg
186.51%
Nanologica AB (publ)’s ROE is greater than Senzime AB (publ) (-39.94%), less than C-Rad AB (publ) (13.82%), less than CellaVision AB (publ) (19.25%), greater than Episurf Medical AB (publ) (-77.80%), greater than Nanexa AB (publ) (-37.13%),
Company | ROE | Market cap |
---|---|---|
-39.94% | $849.88M | |
13.82% | $1.14B | |
19.25% | $4.36B | |
-77.80% | $37.72M | |
-37.13% | $349.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanologica AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nanologica AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Nanologica AB (publ)'s ROE?
How is the ROE calculated for Nanologica AB (publ) (NICA.ST)?
What is the highest ROE for Nanologica AB (publ) (NICA.ST)?
What is the 3-year average ROE for Nanologica AB (publ) (NICA.ST)?
What is the 5-year average ROE for Nanologica AB (publ) (NICA.ST)?
How does the current ROE for Nanologica AB (publ) (NICA.ST) compare to its historical average?